{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:49:54Z","timestamp":1785196194793,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0012"],"award-info":[{"award-number":["ANR-18-RHUS-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00415-024-12252-0","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T19:02:25Z","timestamp":1710183745000},"page":"3279-3290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors"],"prefix":"10.1007","volume":"271","author":[{"given":"Andreu","family":"Vilaseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Villagr\u00e1n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pegat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Benaiteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s Lundahl","family":"Ciano-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Duy","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Birzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-3056","authenticated-orcid":false,"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"12252_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.744653","volume":"12","author":"JE Greenlee","year":"2022","unstructured":"Greenlee JE, Carlson NG, Abbatemarco JR et al (2022) Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis. Front Neurol 12:1\u201316. https:\/\/doi.org\/10.3389\/fneur.2021.744653","journal-title":"Front Neurol"},{"key":"12252_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20427","author":"I Yeh","year":"2021","unstructured":"Yeh I, Bastian BC (2021) Melanoma pathology: new approaches and classification. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.20427","journal-title":"Br J Dermatol"},{"key":"12252_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","volume":"144","author":"DE Elder","year":"2020","unstructured":"Elder DE, Bastian BC, Cree IA et al (2020) The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med 144:500\u2013522. https:\/\/doi.org\/10.5858\/arpa.2019-0561-RA","journal-title":"Arch Pathol Lab Med"},{"key":"12252_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cll.2017.06.001","volume":"37","author":"JS Ko","year":"2017","unstructured":"Ko JS (2017) The immunology of melanoma. Clin Lab Med 37:449\u2013471. https:\/\/doi.org\/10.1016\/j.cll.2017.06.001","journal-title":"Clin Lab Med"},{"key":"12252_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nature06309","volume":"450","author":"CM Koebel","year":"2007","unstructured":"Koebel CM, Vermi W, Swann JB et al (2007) Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450:903\u2013907. https:\/\/doi.org\/10.1038\/nature06309","journal-title":"Nature"},{"key":"12252_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","volume":"235\u201371","author":"MD Vesely","year":"2011","unstructured":"Vesely MD, Kershaw MH, Schreiber RD et al (2011) Natural innate and adaptive immunity. Annu Rev Immunol 235\u201371:235\u2013271","journal-title":"Annu Rev Immunol"},{"key":"12252_CR7","doi-asserted-by":"publisher","first-page":"e1652","DOI":"10.1212\/WNL.0000000000207702","volume":"101","author":"A Vilaseca","year":"2023","unstructured":"Vilaseca A, Mart\u00ednez-S\u00e1ez E, Gonz\u00e1lez V et al (2023) Teaching neuroimage: paraneoplastic cerebellar degeneration and antibodies to TRIM 9 and 67 secondary to melanoma. Neurology 101:e1652\u2013e1653. https:\/\/doi.org\/10.1212\/WNL.0000000000207702","journal-title":"Neurology"},{"key":"12252_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.20238","volume":"56","author":"L Bataller","year":"2004","unstructured":"Bataller L, Sabater L, Saiz A et al (2004) Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol 56:575\u2013579. https:\/\/doi.org\/10.1002\/ana.20238","journal-title":"Ann Neurol"},{"key":"12252_CR9","doi-asserted-by":"publisher","DOI":"10.1017\/9781108696722","volume-title":"Autoimmune encephalitis and related disorders of the nervous system","author":"J Dalmau","year":"2022","unstructured":"Dalmau J, Graus F (2022) Autoimmune encephalitis and related disorders of the nervous system, 1st ed. Cambridge University Press. https:\/\/doi.org\/10.1017\/9781108696722","edition":"1"},{"key":"12252_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/s0035-3787(04)70890-5","volume":"160","author":"J-C Antoine","year":"2004","unstructured":"Antoine J-C, Camdessanche J-P (2004) Paraneoplastic peripheral neuropathies. Rev Neurol (Paris) 160:188\u2013198. https:\/\/doi.org\/10.1016\/s0035-3787(04)70890-5","journal-title":"Rev Neurol (Paris)"},{"key":"12252_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/jnnp.74.4.507","volume":"74","author":"L Kloos","year":"2003","unstructured":"Kloos L, Sillevis Smitt P, Ang CW et al (2003) Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma. J Neurol Neurosurg Psychiatry 74:507\u2013509. https:\/\/doi.org\/10.1136\/jnnp.74.4.507","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12252_CR12","first-page":"86","volume":"21","author":"CD Nicolae","year":"2013","unstructured":"Nicolae CD, Nicolae I (2013) Antibodies against GM1 gangliosides associated with metastatic melanoma. Acta Dermatovenerol Croat 21:86\u201392","journal-title":"Acta Dermatovenerol Croat"},{"key":"12252_CR13","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflam 8:e1014\u2013e1027. https:\/\/doi.org\/10.1212\/NXI.0000000000001014","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"12252_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","volume":"36","author":"MR Rosenfeld","year":"2018","unstructured":"Rosenfeld MR, Dalmau J (2018) Paraneoplastic neurologic syndromes. Neurol Clin 36:675\u2013685. https:\/\/doi.org\/10.1016\/j.ncl.2018.04.015","journal-title":"Neurol Clin"},{"key":"12252_CR15","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1007\/s00520-021-06331-5","volume":"29","author":"A Taliansky","year":"2021","unstructured":"Taliansky A, Furman O, Gadot M et al (2021) Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients: a single center experience. Support Care Cancer 29:7563\u20137568. https:\/\/doi.org\/10.1007\/s00520-021-06331-5","journal-title":"Support Care Cancer"},{"key":"12252_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/WNL.0000000000011795","volume":"96","author":"A Marini","year":"2021","unstructured":"Marini A, Bernardini A, Gigli GL et al (2021) Neurologic adverse events of immune checkpoint inhibitors: a systematic review. Neurology 96:754\u2013766. https:\/\/doi.org\/10.1212\/WNL.0000000000011795","journal-title":"Neurology"},{"key":"12252_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207632","author":"J Pepys","year":"2023","unstructured":"Pepys J, Stoff R, Ramon-Gonen R et al (2023) Incidence and outcome of neurologic immune-related adverse events associated with immune checkpoint inhibitors in patients with melanoma. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000207632","journal-title":"Neurology"},{"key":"12252_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002890","author":"AC Guidon","year":"2021","unstructured":"Guidon AC, Burton LB, Chwalisz BK et al (2021) Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. J Immunother cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002890","journal-title":"J Immunother cancer"},{"key":"12252_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/1740774520942466","volume":"17","author":"M Wang","year":"2020","unstructured":"Wang M, Rajan SS, Jacob AP et al (2020) Retrospective collection of 90-day modified Rankin Scale is accurate. Clin Trials 17:637\u2013643. https:\/\/doi.org\/10.1177\/1740774520942466","journal-title":"Clin Trials"},{"key":"12252_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"12252_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PYK Van den Bergh","year":"2010","unstructured":"Van den Bergh PYK, Hadden RDM, Bouche P et al (2010) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Periphe. Eur J Neurol 17:356\u2013363. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02930.x","journal-title":"Eur J Neurol"},{"issue":"Suppl","key":"12252_CR22","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol 27(Suppl):S21\u2013S24. https:\/\/doi.org\/10.1002\/ana.410270707","journal-title":"Ann Neurol"},{"key":"12252_CR23","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM et al (2021) European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. Eur J Neurol 28:3556\u20133583. https:\/\/doi.org\/10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"key":"12252_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00795-3","author":"J Huang","year":"2023","unstructured":"Huang J, Chan SC, Ko S et al (2023) Global incidence, mortality, risk factors and trends of melanoma: a systematic analysis of registries. Am J Clin Dermatol. https:\/\/doi.org\/10.1007\/s40257-023-00795-3","journal-title":"Am J Clin Dermatol"},{"key":"12252_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12040929","author":"L Filippi","year":"2022","unstructured":"Filippi L, Bianconi F, Schillaci O, Angela Spanu BP (2022) The role and potential of 18 F-FDG PET\/CT in malignant melanoma\u202f: prognostication, monitoring response to targeted. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics12040929","journal-title":"Diagnostics"},{"key":"12252_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.rdc.2020.05.006","volume":"46","author":"S Moghadam-Kia","year":"2020","unstructured":"Moghadam-Kia S, Oddis CV, Ascherman DP, Aggarwal R (2020) Risk factors and cancer screening in myositis. Rheum Dis Clin North Am 46:565\u2013576. https:\/\/doi.org\/10.1016\/j.rdc.2020.05.006","journal-title":"Rheum Dis Clin North Am"},{"key":"12252_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/mus.26028","volume":"57","author":"YA Rajabally","year":"2018","unstructured":"Rajabally YA, Attarian S (2018) Chronic inflammatory demyelinating polyneuropathy and malignancy: a systematic review. Muscle Nerve 57:875\u2013883. https:\/\/doi.org\/10.1002\/mus.26028","journal-title":"Muscle Nerve"},{"key":"12252_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00415-022-11356-9","volume":"270","author":"M Villagr\u00e1n-Garc\u00eda","year":"2023","unstructured":"Villagr\u00e1n-Garc\u00eda M, Mu\u00f1iz-Castrillo S, Ciano-Petersen NL et al (2023) Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review. J Neurol 270:283\u2013299. https:\/\/doi.org\/10.1007\/s00415-022-11356-9","journal-title":"J Neurol"},{"key":"12252_CR29","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/1097-0142(19890315)63:6<1166::AID-CNCR2820630621>3.0.CO;2-5","volume":"63","author":"T Tsuchida","year":"1989","unstructured":"Tsuchida T, Saxton RE, Morton DLIR (1989) Gangliosides of human melanoma. Cancer 63:1166\u20131174","journal-title":"Cancer"},{"key":"12252_CR30","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.51.6.1738","volume":"51","author":"MD Weiss","year":"1998","unstructured":"Weiss MD, Luciano CA, Dalakas MC, Quarles RH (1998) Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology 51:1738\u20131741","journal-title":"Neurology"},{"key":"12252_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad186","author":"A Farina","year":"2023","unstructured":"Farina A, Birzu C, Elsensohn M et al (2023) Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcad186","journal-title":"Brain Commun"},{"key":"12252_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10633-020-09795-8","volume":"142","author":"L Poujade","year":"2021","unstructured":"Poujade L, Samaran Q, Mura F et al (2021) Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone. Doc Ophthalmol 142:257\u2013263. https:\/\/doi.org\/10.1007\/s10633-020-09795-8","journal-title":"Doc Ophthalmol"},{"key":"12252_CR33","doi-asserted-by":"publisher","first-page":"e2442","DOI":"10.1212\/WNL.0000000000010632","volume":"95","author":"E Sechi","year":"2020","unstructured":"Sechi E, Markovic SN, McKeon A et al (2020) Neurologic autoimmunity and immune checkpoint inhibitors: autoantibody profiles and outcomes. Neurology 95:e2442\u2013e2452. https:\/\/doi.org\/10.1212\/WNL.0000000000010632","journal-title":"Neurology"},{"key":"12252_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ced.14095","volume":"45","author":"S Elsheikh","year":"2020","unstructured":"Elsheikh S, Gurney SP, Burdon MA (2020) Melanoma-associated retinopathy. Clin Exp Dermatol 45:147\u2013152. https:\/\/doi.org\/10.1111\/ced.14095","journal-title":"Clin Exp Dermatol"},{"key":"12252_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5694\/mja16.00586","volume":"205","author":"JM Bourke","year":"2016","unstructured":"Bourke JM, O\u2019Sullivan M, Khattak MA (2016) Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors). Med J Aust 205:418\u2013424. https:\/\/doi.org\/10.5694\/mja16.00586","journal-title":"Med J Aust"},{"key":"12252_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17046","author":"D Castanares-Zapatero","year":"2024","unstructured":"Castanares-Zapatero D, Verleye L, Devos C et al (2024) Survival of patients with unfavorable prognosis cutaneous melanoma with increased use of immunotherapy agents: a population-based study in Belgium. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.17046","journal-title":"Int J Dermatol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12252-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T15:11:34Z","timestamp":1716995494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12252-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["12252"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12252-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by a public grant overseen by the French national research agency (Agence nationale de la recherch\u00e9, ANR) as part of the Investissements d\u2019Avenir program (ANR-18-RHUS-0012). This work was performed within the framework of the LABEX CORTEX (ANR-11-LABX-0042) of the Universit\u00e9 Claude Bernard Lyon 1, within the program Investissements d\u2019Avenir (ANR-11-LABX-0042) operated by the ANR. Andreu Vilaseca has received a Rio Hortega grant (CM22\/00247) by Institute of Health Carlos III (ISCIII). Macarena Villagr\u00e1n-Garc\u00eda is supported by a research grant from Fundaci\u00f3n Alfonso Mart\u00edn Escudero (Spain).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All patients provided written informed consent for the storage and use of their serum, CSF, and clinical information for research purposes. The study was approved by the Institutional Review Board of the University Claude Bernard Lyon 1 and Hospices Civils de Lyon (ICARE NCT-03963700). All data is available upon request for validation and reproduction of the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}